
January 15, 2019 Manufacturing and Production, Research and Development Cancer, immunotherapy, nature, oncology, research, tumour

January 15, 2019 Manufacturing and Production, Research and Development Boehringer, COPD, Stiolto Respimat, pharma, trial failure, verona pharma

January 15, 2019 Manufacturing and Production Cancer, Lutathera, NL, Netherlands, Novartis, oncology

January 15, 2019 Manufacturing and Production, Sales and Marketing Breast cancer; Roche; Scotland, NHS, Perjeta, UK, pharma

January 15, 2019 Manufacturing and Production Bernie Sanders, Elijah cummings, congress, pharma, pricing, us politics

January 14, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

January 14, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alström syndrome, patient experience, pharma, rare disease

January 11, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Bristol-Myers Squibb, Shire, Takeda, bristol myers squibb, death row, pharma, top 10

January 10, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

January 10, 2019 Manufacturing and Production AstraZeneca, US, job cuts, pharma

January 10, 2019 Manufacturing and Production FDA, approval, generic drugs, generics, regulation

January 9, 2019 Manufacturing and Production, Research and Development India, Pfizer, pharma

January 9, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bluebird Bio, appointment, pharma

January 8, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cancer, journal, oncology

January 8, 2019 Manufacturing and Production, Research and Development University of Birmingham, atrial fibrillation, biomarkers, pharma